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Available online 21 March 2017AbstractIn humans the steroid 5a-reductase (SRD5A) family comprises five integral membrane enzymes that carry out reduction of a double bond in
lipidic substrates: D4-3-keto steroids, polyprenol and trans-enoyl CoA. The best-characterized reaction is the conversion of testosterone into the
more potent dihydrotestosterone carried out by SRD5A1-2. Some controversy exists on their possible nuclear or endoplasmic reticulum
localization.
We report the cloning and transient expression in HeLa cells of the five members of the human steroid 5a-reductase family as both N- and C-
terminus green fluorescent protein tagged protein constructs. Following the intrinsic fluorescence of the tag, we have determined that the
subcellular localization of these enzymes is in the endoplasmic reticulum, upon expression in HeLa cells. The presence of the tag at either end of
the polypeptide chain can affect protein expression and, in the case of trans enoyl-CoA reductase, it induces the formation of protein aggregates.
© 2017 Published by Elsevier B.V. on behalf of Socie´te´ Franc¸aise de Biochimie et Biologie Mole´culaire (SFBBM). This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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In humans the steroid 5a-reductase family (SRD5A) com-
prises five membrane embedded enzymes that carry out the
reduction of a double bond of lipidic substrates. They can be
traced back to a common ancestor that split in three sub-
families (SRD5A1-2, SRD5A3 and TECR-TECRL). Members* Corresponding author. Dept. of Biochemical Sciences, Sapienza University
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the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).of the three subfamilies are found in all primary eukaryotic
species from plant, amoeba and yeast up to vertebrates, indi-
cating that the split arose in early eukaryota [1]. The dupli-
cation of an ancestral gene led to substrate diversification and
acquisition of a central role in vertebrates in the context of the
complex physiological roles of steroids.
SRD5A1 and SRD5A2 carry out the NADPH-dependent
reduction of the D4 group (double bond) of C-19 and C-21
steroids into 5a-stereoisomers [2]. This reaction yields dihy-
drotestosterone, a more potent derivative of testosterone [3].
The first identified role of dihydrotestosterone is to trigger the
development of external genitalia in the male fetus, aschimie et Biologie Mole´culaire (SFBBM). This is an open access article under
100 A. Scaglione et al. / Biochimie Open 4 (2017) 99e106dramatically brought to evidence by the identification of fa-
milial incomplete male pseudo-hermaphroditism, a congenital
condition due to mutations of the SRD5A2 gene [4]. Due to
their activity on testosterone, both SRD5A1 and SRD5A2 can
be viewed as pivotal factors in several physio-pathological
conditions, from benign prostatic hyperplasia and prostatic
cancer to acne and male pattern baldness [5,6]. Two com-
mercial drugs, finasteride and dutasteride, are used in therapy
for benign prostatic hyperplasia and, in the case of finasteride,
also for male pattern baldness.
The action of SRD5A1 and SRD5A2 on progesterone,
testosterone and other related steroids is also a committing
step for the production of neurosteroids. These are among the
strongest modulators of GABA(A) receptors with anticonvul-
sant, antidepressant and anxiolytic effects [7].
The expression of SRD5A1 and SRD5A2 was studied in
several organs and tissues, with results depending on the
methodology (antibody, mRNA analysis, in situ, after protein
extraction, etc.) and on tissue preparation and origin (for a
review see Ref. [8]). Expression of SRD5A1 is consistently
reported in the brain, liver and sebaceous glands, whereas
SRD5A2 is mainly found in the urogenital tract, genital skin,
liver and transiently in the brain.
A third member, SRD5A3, has testosterone reductase ac-
tivity, and seems to play a role in the onset of hormone re-
fractory prostate cancer [9]. Surprisingly, inactivating
mutations of the SRD5A3 gene cause a rare congenital neu-
rodevelopmental disorder. This is possibly related to the fact
that SRD5A3 is also endowed with polyprenol reductase ac-
tivity, thus carrying out one of the earliest steps of protein N-
linked glycosylation [10]. SRD5A3 was ubiquitously detected
in human healthy tissues and is overexpressed in prostate and
breast malignancies [11].
Trans-2-Enoyl-CoA reductase (TER or TECR) comes as a
more recent addition to the SRD5A family. This gene, when
mutated, causes a rare autosomic syndrome, nonsyndromic
mental retardation, and the protein carries out the fourth step
of very long-chain fatty acid synthesis and sphingosine
degradation [12]. TECR expression seems ubiquitous in man
and mouse organs by Northern blot analysis [13], with high
expression in the nervous system [14] consistently with its
involvement in the synthesis of membrane lipids and with
congenital neurological impairment arising from mutations.
A fifth gene of unknown function, called TECR-like
(TECRL), was identified in vertebrates through sequence ho-
mology with TECR [1].
During over 30 years of research on SRD5A enzymes, their
purification in an active form has proven elusive. Nevertheless,
biochemical studies on the microsomal fraction from liver and
prostate led to the characterization of the main enzymatic
parameters of SRD5A1, SRD5A2 [15] and, to a lesser extent,
SRD5A3 proteins [8,16].
Sequence analysis and biochemical studies of the SRD5A
family members did not highlight, to our knowledge, the
presence of post-translational modifications, such as specificproteolytic signals, glycosylation, phosphorylation, acylation
or isoprenylation. Similarly, no canonical signal for a specific
subcellular localization was reported.
The subcellular localization of the SRD5A enzymes is
significant to their functions since it might affect binding of
reaction products to nuclear steroid receptors in the same cell
or diffusion to other cells. We have undertaken a systematic
analysis to address their localization. We have cloned all
members of the human SRD5A family in vectors for transient
expression in mammalian cells, fusing at either C- or N-ter-
minus the enhanced green florescent protein (eGFP). We
present a comprehensive assessment of their localization as a
guideline for functional analysis in cells and for production
and purification for structural and biochemical studies.
2. Material and methods2.1. Cloning and plasmidsPlasmids containing the cDNA sequence for human
SRD5A1, SRD5A2, SRD5A3 and TECR were purchased from
the IMAGE Consortium (www.imageconsortium.org), the se-
quences of the human TECR and TECRL genes were
synthesized.
The five genes were cloned into the pTriEx modifed vectors
pNYCOMPS_RB_30_GFP and pNYCOMPS_RB_33_GFP,
using the ligase independent cloning method described in
Ref. [17]. These vectors are designed for mammalian, insect
and bacterial protein expression and they add at the N-termi-
nus of the protein coded by the cloned gene a cassette con-
taining sequentially: ten histidines tag, FLAG tag, eGFP and
TEV protease cleavage site at the amino terminus of the gene
of interest for pNYCOMPS_RB_33_GFP. For the pNY-
COMPS_RB_30_GFP the C-term is followed by: TEV pro-
tease cleavage site, eGFP, 10 histidine tag and FLAG-tag (see
Fig. 1). These plasmids allow detection and expression of the
cloned protein upon transient transfection of mammalian or
insect cells, or expression in bacteria.2.2. Cell culture and transfectionHEK293 and HeLa cells were grown in Dulbecco's modi-
fied Eagle's medium (DMEM) supplemented with 10% fetal
calf serum, 2% L-glutamine, and 2% penicillin/streptomycin in
humidified atmosphere at 37 C in 5% CO2. Confluent cell
layers were trypsinized, and replated on poly-L-lysine coated
coverslips in DMEM medium, which was replaced by serum-
free media the next day.
Transfections were performed using Lipofectamine 2000,
all controls were transfected with peGFP-N1 vector. Cells
were harvested 48 h after transfection and analyzed by
Western blot or immunofluorescence. The transfection rate
was calculated after staining the cells on the coverslip
with DAPI and counting eGFP-positive cells/DAPI-stained
nuclei.
Fig. 1. Schematic cartoon and expression of human SRD5Аs, TECR and TECRL eGFP-fusion proteins. (A) Diagram of SRD5А constructs showing position
of eGFP both at N- or C-term; the FLAG tag is omitted. (B) Extract from HeLa cells transfected with human SRD5А1, SRD5А2, SRD5А3 expression plasmids for
C-term and N-term eGFP fusions, untransfected and eGFP-transfected cells. Different exposure times are shown (50 s for lanes 1e5, 25 s for lanes 6e8). (C)
Extract from HeLa cells transfected with human TECR, TECRL (C-term and N-term eGFP fused). Proteins were visualized using anti-eGFP antibody after 10 s
exposure (lanes 9e12).
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(20 mM Hepes, pH 7.0, 200 mM NaCl, 2 mM 2-
Mercaptoethanol) supplemented with 1% b-D-Maltopyrano-
side and protease inhibitor cocktail (Roche). After incubation
for 90 min at 4 C, the lysates were clarified by centrifugation
at 12,000g at 4 C for 20 min. Protein concentration was
determined by the Bradford method. Equal amounts of pro-
teins (40 mg) were loaded on 4e12% SDS-PAGE. Samples
were electrotransferred onto nitrocellulose membranes. The
membranes were blocked with 5% milk in TBS/0.1% Tween
20 (TBST) on an orbital shaker for 1 h and incubated for 1 h
with rabbit monoclonal anti-GFP (1:1000, Roche). Following
five TBSTwashes, the membranes were incubated for 1 h with
horseradish peroxidase-conjugated anti-rabbit antibody in
TBST. Membranes were developed by enhanced chem-
iluminescence, and detected proteins were identified by their
molecular sizes.2.4. Immunofluorescence and microscopyCells grown on coverslips were washed in PBS and fixed at
room temperature by: (a) 3.7% PFA/30 mM sucrose in PBS,
10 min, (b) 5 min of membrane permeabilization in 0.1%TritonX-100 in PBS, and (c) 10 min in 0, 1 M Glycine.
Blocking and incubations were performed in PBS/0.05%
Tween 20/3% BSA. Incubation with primary antibodies was
performed for 16 h at 4 C. Secondary antibodies were incu-
bated for 45 min at room temperature. Cells were counter-
stained with 4,6-diamidino-2-phenylindole (DAPI, 0.1 mg/ml)
and mounted using Vectashield (Vector Laboratories).
Primary antibodies were: mouse anti-Erp57 (1:200,
ab13506, Abcam), rabbit anti-Giantin (1:500, ab24586;
Abcam), rabbit anti-pericentrin (2 mg/ml, ab4448; Abcam) and
mouse anti-a-tubulin (1:2000, B-5-1-2, SigmaeAldrich).
Secondary antibodies were conjugated to Cy3, Texas red,
FITC or Alexa647 (Vector Laboratories). Samples were
analyzed using a Nikon Eclipse 90i microscope with a Qicam
Fast 1394 CCD camera (QImaging). Image acquisition,
deconvolution and Extended Depth of Focus on Z-serial op-
tical sections were performed using Nis-Elements AR4.2
(Nikon); images were further processed with Adobe Photo-
shop CS 8.0.
The ProteoStat® aggresome detection kit was used to detect
protein aggregates in HeLa cells transfected for SRD5A pro-
tein expression. Samples were analyzed using an Olympus
FLUOVIEW FV10i-DOC Confocal Laser Scanning Micro-
scope, equipped with a 60 phase contrast water-immersion
objective (N.A.1.2) and an analog detector (PMT), using a
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Cyan filter set for the eGFP. Image acquisition and analysis
were performed using an Image Processing and Analysis in
Java software (ImageJ); images were further processed with
Adobe Photoshop CS 8.0.
3. Results3.1. Protein expressionProtein expression was assessed by immunoblot on
detergent-solubilized whole lysates of HeLa cells transfected
with the five members of the human SRD5A family. The
antibody recognized eGFP fused either at the N- or at the C-
term. We observed expression for all constructs, albeit with
significant quantitative variations, as high as 100-fold (Fig. 1).
SRD5A2, tagged at C- or N-term, and SRD5A1 when tagged
at the N-term, show faint bands by immunoblot analysis. In
parallel, we observed on duplicate slides that their transfection
efficiency was only between 5% and 2%, thus explaining the
weak signal detected in Western blots. The not transfected
control shows no reaction with the anti-GFP antibody as ex-
pected. In extract from cells transfected with the vector for
eGFP expression, the antibody recognizes a single polypeptide
with the correct molecular weight (~27 kDa). Intensely stained
bands, of apparent molecular weight corresponding to eGFP-
fused SRD5A proteins (~56 kDa), are evident for cells trans-
fected with C-term tagged eGFP-SRD5A1 (Fig. 1; lane 1), and
with SRD5A3 eGFP-tagged at either end (Fig. 1; lanes 5 & 6).
On the other hand, TECR and TECRL have a higher expected
molecular weight (~62 kDa) and consistently their transient
expression yielded slower-migrating bands on the immunoblot
(Fig. 1; lanes 9e12).
In all samples, the anti-GFP antibody also recognized
higher molecular weight species, which we attribute to an
oligomeric state of SRD5A membrane proteins, which were
not dissociated in SDS PAGE due to their very high hydro-
phobic character. Indeed, no high molecular weight signals
were detected in control samples expressing eGFP not fused to
SRD5A proteins.3.2. Subcellular localization of eGFP tagged SRD5A
proteinsThe localization of each eGFP-tagged protein was exam-
ined relative to relevant markers of the membrane compart-
ments, i.e. the ER resident protein Erp57 and the Golgi
compartment resident protein Giantin [18e20]. Due to the
fact that preliminary assays depicted diversified patterns for
these markers, especially Giantin, in individual cells, we first
evaluated the distribution of ERp57 and Giantin in co-
staining with cell cycle markers, i.e. the centrosomal pro-
tein pericentrin (to identify interphase stages: one spot, G1
phase; two mature spots, late S and G2 phases) and the
microtubule constituent a-tubulin (to identify mitosis). This
allowed us to exclude that Erp57 and Golgi distribution
patterns undergo significant remodeling during the cell cycleand avoid inaccurate evaluation of SRD5As co-localization
(Fig. S1).
Fig. 2A shows that N-term and C-term eGFP-tagged
SRD5A1, SRD5A2 and SRD5A3 proteins expressed upon
transfection reside in the ER, as indicated by co-localization
with Erp57 and the overall distribution of the green fluores-
cence relative to Erp57. No nuclear localization was observed.
On the other hand, eGFP alone localizes in the nucleus
(Fig. S1). These observations are consistent with the ER
localization of SRD5A proteins being genuine and not
attributable to the presence of the eGFP tag.
Also for TECR and TECRL members, both the N- and C-
term eGFP-tagged proteins, with one exception, showed a
pattern and co-localization behavior corresponding to ER
membrane insertion (Fig. 2B). A remarkable exception was
observed in cells expressing the C-term eGFP-tagged TECR,
where only sparse bright dots were detected, moreover the
localization of the ER marker Erp57 was less diffuse than in
non-transfected cells (Fig. S1). In some cases, there was some
limited overlap between Erp57 and C-term eGFP-tagged
TECR proteins (individual z-stack scanning are given in
Fig. S2). On the other hand, the lack of co-localization with
Giantin for TECR and TECRL, in both the C- and N-term
eGFP-tagged proteins (Fig. 3A), ruled out the possibility that
they might localize to the Golgi.
Staining with ProteoStat® that highlights the presence of
aggresomes and protein aggregates [21], showed that the green
fluorescent dots observed for C-term eGFP-tagged TECR form
foci that are contained within larger aggregates, providing
evidence consistent with the fact that the presence of eGFP at
the C-term of TECR promotes protein misfolding, at least in
part, resulting in aggregation (Fig. 3B).
4. Discussion
The subcellular localization of members of the SRD5A
family in humans and also in mouse is controversial, espe-
cially as far as SRD5A1 and SRD5A2 are concerned. Russell
and Wilson reported indications of a differential organ-specific
subcellular localization, nuclear in the prostate and cyto-
plasmic in the liver, regardless of the enzyme variant
(SRD5A1 or SRD5A2) [15,22], or that the localization for
both is in the endoplasmic reticulum [23]. Early findings based
mainly on cellular component fractionation [24,25], but later
also on immunohistochemical studies [26,27], indicate that the
SRD5A1 enzyme localization is mainly within nuclear or
perinuclear membranes whereas the SRD5A2 protein is found
in the cytoplasm, most likely in the ER.
Protein expression in mammalian (human HeLa and
HEK293 and simian COS-M6), as well as yeast and insect
cells, again yielded contradictory results. Some authors have
reported that human SRD5A1 is associated with nuclear
fractions upon expression in insect Sf9 cells [28,29] but later
papers [30] have instead reported retrieval of enzyme activity
from the microsomal fraction. Expression of SRD5A2 and
SRD5A1 in HEK293 and in LNGK-9 PCa cells yielded ac-
tivity in the nuclear and microsomal fractions [31,32]. Upon
Fig. 2. Fluorescence of human SRD5As (A) and TECR, TECRL (B) proteins in relation to endogenous ERp57. SRD5A1, SRD5A2 and SRD5A3 proteins
eGFP-tagged at C- or N-term (A), N-term eGFP-tagged TECR and N- and C-term eGFP-tagged TECRL proteins (B) reside in the ER, as indicated by co-
localization with Erp57 and overall distribution of green fluorescence relative to Erp57. eGFP C-term TECR (B, left column) shows diffuse bright dots indi-
cated by white arrows, with only limited overlap with ERp57. Deconvolutions plus Extended Depth of Focus (EDF) were performed on Z-stack series (13 frames-0,
6 mm each). The scanning of Z-stacks for red-framed images in B, with eGFP C-term TECR is given in supplementary Fig. 2. Scale bar ¼ 10 mm,
Magnification ¼ 100.
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appears to be associated to nuclei, whereas SRD5A2 is in the
microsomal fraction [33]. Immunostaining for SRD5A2
showed presence of the enzyme in the cytoplasm throughout
most regions of the brain [34]. Finally, it was reported thatglioma cells express SRD5A1 in the perinuclear space or in
the cytoplasm, depending on culture conditions [35].
As far as the third isoform of testosterone a-reductase
(SRD5A3, also known as polyprenol reductase), available data
report recovery from the microsomal fraction [8] and transient
Fig. 3. Fluorescence analysis of human TECR and TECRL relative to
Giantin and fluorescence of eGFP C-term TECR and aggregates/aggre-
somes in the cytoplasm. (A) TECR proteins do not localize in the Golgi
apparatus, as associated eGFP fluorescence shows a broader distribution
around, but not coinciding with, the Giantin signal. Scale bar ¼ 10 mm,
Magnification ¼ 100. (B) Localization of eGFP C-term TECR and aggre-
somes in HeLa cells after treatment with ProteoStat® dye for 30 min. Fluo-
rescence of C-term eGFP-tagged TECR partially co-localizes with aggregated
proteins. Scale bar ¼ 10 mm, Magnification ¼ 60.
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no detectable activity [36]. For the TECR enzyme, immuno-
histochemistry has clearly suggested a localization in the ER
[12]. No data is available for the TECRL that has been
described only at the gene level.
SRD5A family members share significant sequence simi-
larity, having likely evolved via duplication from an ancestral
gene (sequence alignment is shown in Fig. S3). In localization
studies, in order to eliminate any potential ambiguities due to
antibody specificity, we directly examined each of the five
human SRD5A family members by taking advantage of the
fluorescent emission of the eGFP fusion tag in transfected
HeLa cells. The caveat of aberrant subcellular localization due
to the presence of the eGFP tag calls for careful consideration,
and we therefore systematically compared the localization of
C-term and N-term tagged paired constructs for each SRD5A
member in parallel experiments.
The effect of a GFP tag on membrane protein localization
and expression can vary, nevertheless this method is reported
as a valid tool in subcellular localization studies [37e39]. The
positioning on the C- or N-term of the polypeptide chain can
affect protein expression and stability and its effect varies
depending on the system under analysis. In an extended study
on the effects on GFP tagging on subcellular localization [40]
C-term tagging is reported to maintain physiological locali-
zation, whereas N-term affected it, contrarily to what we
observed with human TECR.
The data we obtained with proteins fused with eGFP at the
N-term indicate that all members of the SRD5A family reside
in the endoplasmic reticulum, when transient expression is
carried out in HeLa cells. This is also evident for protein
constructs where the fusion with eGFP was at the C-term, with
the exception of TECR. TECR was previously localized in the
endoplasmic reticulum by immunofluorescence staining in
transiently transfected HeLa cells [10]. This, and the patterns
obtained here with the C-term chimaera, allowed us to
conclude that the presence of eGFP at the C-term affects TECR
folding, leading to the accumulation of aggregated protein.
In the SRD5A proteins, N-term eGFP-tagging reduces
expression for SRD5A1, TECRL and TECR, and for the latter
C-term eGFP-tagging promotes aggregation. On the other
hand, for SRD5A3, expression is somewhat higher in the N-
term eGFP-tagged form. Thus, even within a family of pro-
teins, the effect of fusion tags on protein expression is not
predictable and has to be assessed for each member. Our re-
sults indicate that membrane protein tagging with eGFP, which
is commonly used to assess protein expression by fluorescence-
coupled size-exclusion chromatography (FSEC) [41], can lead
to very different expression yields, depending on the tag po-
sition, and that higher expression levels, as in the case of C-
term tagged TECRL with respect to the N-term tagged form,
can underlie unfolding and aberrant subcellular localization.
In summary, the present studies support the conclusion that
isozymes 1 and 2 of testosterone 5a-reductase (SRD5A1 and
SRD5A2) are both localized in the ER, upon transient
expression in HeLa cells, our data are a valuable contribution
to clarify the contradictory reports detailed above, although
105A. Scaglione et al. / Biochimie Open 4 (2017) 99e106any ultimate conclusion on the intracellular localization of
SRD5As should be validated in other cell lines and comple-
mentary experimental settings.
Moreover, the subcellular localization in the ER for
SRD5A3 is consistent with the reported microsomal sub-
fractionation. Finally, we show that the previously uncharac-
terized TECRL gene can be expressed in human cells and that
its product is a protein residing in the ER membrane.
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